Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates
Agilon Health (AGL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.41 per share a year ago.
AGL Energy Limited (AGLNF) Q2 2025 Earnings Conference Call Transcript
AGL Energy Limited (OTCPK:AGLNF) Q2 2025 Earnings Conference Call February 11, 2025 7:00 PM ET Company Participants Damien Nicks - MD and CEO Gary Brown - CFO Jo Egan - Chief Customer Officer Markus Brokhof - COO Conference Call Participants Tom Allen - UBS Dale Koenders - Barrenjoey Anthony Moulder - Jefferies Rob Koh - Morgan Stanley Gordon Ramsay - RBC Capital Markets Ian Myles - Macquarie Henry Meyer - Goldman Sachs Operator Thank you for standing by, and welcome to the AGL Energy Half Year Results Briefing Conference Call. All participants will be in listen-only mode.
New Strong Sell Stocks for January 28th
AGL, ASHTY and CCOZY have been added to the Zacks Rank #5 (Strong Sell) List on January 28, 2024.
New Strong Sell Stocks for January 24th
WMS, AGL and EADSY have been added to the Zacks Rank #5 (Strong Sell) List on January 24, 2025.
New Strong Sell Stocks for January 21st
VLVLY, AGL and APOG have been added to the Zacks Rank #5 (Strong Sell) List on January 21, 2025.
New Strong Sell Stocks for December 31st
AGL, AMPH and CR have been added to the Zacks Rank #24 (Strong Sell) List on December 31, 2024.
New Strong Sell Stocks for December 13th
AGL, BKGFY and BERY have been added to the Zacks Rank #5 (Strong Sell) List on December 13, 2024.
New Strong Sell Stocks for December 4th
ATI, ARLP and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 4, 2024.
New Strong Sell Stocks for December 2nd
ATI, ATS and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 2, 2024.
Agilon Health price target lowered to $2 from $5 at Barclays
Barclays lowered the firm's price target on Agilon Health to $2 from $5 and keeps an Underweight rating on the shares. The company's Q3 results underscore the lack of visibility into real-time trends and limited ability to take control of negative developments, the analyst tells investors in a research note.
agilon health, inc. (AGL) Q3 2024 Earnings Call Transcript
agilon health, inc. (NYSE:AGL ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Leland Thomas - Senior Manager-Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Adam Ron - Bank of America George Hill - Deutsche Bank Sameer Patel - Evercore Ryan Langston - TD Cowen Stephen Baxter - Wells Fargo Andrew Mok - Barclays Jack Slevin - Jefferies Michael Ha - Baird Thomas Keller - RBC Daniel Grosslight - Citi Operator Good afternoon and thank you for joining the agilon health Third Quarter 2024 Earnings Conference Call.
